EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Cost-effectiveness of diabetic retinopathy screening for newly diagnosed type 2 diabetic patients: A nationwide population-based propensity score-matched cohort study

Yu-Chien Chung, Yi-Wei Kao, Yen-Chun Huang, Pei-En Chen, Shu-Chen Liao, Chih-Kuang Liu, Mingchih Chen

Asia-Pacific Journal of Ophthalmology · 2024-05 · 13 (3) · 100071

DOI: 10.1016/j.apjo.2024.100071 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Asia-Pacific Journal of Ophthalmology, 2024-05. Verfasst von Yu-Chien Chung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan; Graduate Institute of Business…. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Type 2, Propensity Score, Cost-Benefit Analysis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: This study investigated the association between the frequency of screening for diabetic retinopathy (DR) versus the development of DR and corresponding medical expenses among patients newly diagnosed with type 2 diabetes mellitus (T2DM). METHODS: This longitudinal, population-based study used the Taiwan National Health Insurance Research Database (2004 to 2020) as a data source. Propensity score matching (PSM) (sex, age, comorbidities and concurrent medication use) was employed in the grouping of T2DM patients according to different frequency of DR screening. Outcome measures included the proportion of patients who developed DR, who received DR treatment, and the associated medical expenses and hospitalizations. RESULTS: The 17-year cohort included 337,046 patients. After PSM, three groups each containing 35,739 patients were assembled and analyzed. Compared to low-frequency screening, high-frequency screening was more effective in detecting patients requiring treatment; however, the net cost for treatment was significantly lower. Standard-frequency screening appears to provide the best balance in terms of DR detection, diagnosis interval, the risk of DR-related hospitalization, and DR treatment costs. CONCLUSIONS: In this real-world cohort study covering all levels of the healthcare system, infrequent screening was associated with delayed diagnosis and elevated treatment costs, while a fundus screening interval of 1-2 years proved optimal in terms of detection and medical expenditures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyDiabetes Mellitus, Type 2Propensity ScoreCost-Benefit AnalysisMass ScreeningHumansFemaleMaleMiddle AgedTaiwanAgedRetrospective StudiesAdultHealth Care CostsFollow-Up Studies

Stichwörter der Autor:innen

Diabetic retinopathyNewly diagnosed diabetesScreeningType 2 diabetes mellitus

Autor:innen und Institutionen

  • Department of Ophthalmology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan; Graduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City, Taiwan.
  • Artificial Intelligence Development Center, Fu Jen Catholic University, New Taipei City, Taiwan; Department of Applied Statistics and Information Science, Ming Chuan University, Taoyuan City, Taiwan.
  • Department of Artificial Intelligence, Tamkang University, No.151, Yingzhuan Rd., Tamsui Dist., New Taipei City 251301, Taiwan, ROC.
  • Institute of Health Policy and Management, National Taiwan University, Taipei, Taiwan.
  • Graduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City, Taiwan; Department of Orthopaedics, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan.
  • Graduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City, Taiwan; Camillian St Mary's Hospital Luodong, Yilan, Taiwan.

Zitieren

APA

Chung, Y. C., Kao, Y. W., Huang, Y. C., Chen, P. E., Liao, S. C., Liu, C. K., & Chen, M. (2024). Cost-effectiveness of diabetic retinopathy screening for newly diagnosed type 2 diabetic patients: A nationwide population-based propensity score-matched cohort study. Asia-Pacific Journal of Ophthalmology, 13(3), 100071. https://doi.org/10.1016/j.apjo.2024.100071

Vancouver

Chung YC, Kao YW, Huang YC, Chen PE, Liao SC, Liu CK, et al. Cost-effectiveness of diabetic retinopathy screening for newly diagnosed type 2 diabetic patients: A nationwide population-based propensity score-matched cohort study. Asia-Pacific Journal of Ophthalmology. 2024;13(3):100071. doi:10.1016/j.apjo.2024.100071

BibTeX
@article{Chung2024,
  author = {Chung, Yu-Chien and Kao, Yi-Wei and Huang, Yen-Chun and Chen, Pei-En and Liao, Shu-Chen and Liu, Chih-Kuang and Chen, Mingchih},
  title = {Cost-effectiveness of diabetic retinopathy screening for newly diagnosed type 2 diabetic patients: A nationwide population-based propensity score-matched cohort study},
  journal = {Asia-Pacific Journal of Ophthalmology},
  year = {2024},
  volume = {13},
  number = {3},
  pages = {100071},
  doi = {10.1016/j.apjo.2024.100071}
}
Kostenlos starten →